Higher expression of oncoproteins c-myc, c-erbB-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumors

Annals of Surgical Oncology

Volumn 3, Issue 6, 1996, Pages 574-579

  Crowe, Philip J ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

2 neu; C erbB; C myc; M etastatic colorectal cancer; Oncoprotein; p53; PCNA

Indexed keywords

CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MYC PROTEIN; PROTEIN P53;

ARTICLE; CHEMISTRY; COLORECTAL TUMOR; COMPARATIVE STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER TUMOR; METASTASIS; PATHOLOGY;

COLORECTAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; NEOPLASM METASTASIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, ERBB-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030277219     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02306092     Document Type: Article

References (5)

1. Fidler IJ, Hart IR. Biologic diversity in metastatic neoplasms - origins and implications. Science 1982;217:998-1001.
2. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
3. Rigas B. Oncogenes and suppressor genes: their involvement in colon cancer. J Clin Gastroenterol 1990;12:494-9.
4. Menko FH. Genetjcs of colorectal cancer for clinical practice. The Netherlands: Kluwer Academic Publishers, 1993:135-6.
5. Jen J, Kim H, Piantadosi S, Liu ZF, Levitt RC, Sistonen P, Kinzler KW, et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994;331:213-21.